We studied whether regular, active-duty servicemen deployed to the Persian Gulf War were at increased risk of testicular cancer compared with nondeployed Gulf War-era servicemen from August 1991 through March 31, 1996, using a Cox proportional hazards model for survival analysis with covariates. Race was an important predictor of hospitalization for testicular cancer [rate ratio (RR) = 0.19; 95% confidence interval (CI) = 0.12-0.29 for blacks, and RR = 0.59; 95% CI = 0.39-0.91 for Hispanics, other, and unknown (combined), relative to whites]. Age effects were modest (RR = 1.19; 95% CI = 0.91-1.56 for those of ages 22-25 years, and RR = 1.24; 95% CI = 0.96-1.59 for those of ages 26-31 years, compared with those of ages 17-21 years). Risk also varied with occupation (RR = 1.56; 95% CI = 1.23-2.00 for those in electronic equipment repair; RR = 1.26; 95% CI = 1.01-1.58 for those in electrical/mechanical repair; and RR = 1.42; 95% CI = 0.93-2.17 for those in construction-related trades, compared with those in other occupations). Deployment status was not important (RR = 1.05; 95% CI = 0.86-1.29 for the deployed compared with the nondeployed). There was an increase in testicular cancer in the deployed group in the immediate postwar period that was consistent with a previous report of a standardized RR of 2.12; 95% CI = 1.11-4.02 (compared with the nondeployed group) in the last 5 months of 1991, but by 4 years after the end of deployment, the cumulative risks for the two groups were not different. An additional analysis suggested that the immediate postwar increase in the deployed was likely due to regression to the mean after a healthy serviceman selection effect for deployment and the deferment of care during deployment.
Download full-text PDF |
Source |
---|
BJUI Compass
January 2025
Department of Urology Guy's & St. Thomas' Hospital, and Faculty of Life Sciences & Medicine, King's College London London UK.
Objectives: This study aimed to assess current international clinician practices, attitudes and barriers related to testicular prosthesis implantation in patients with testicular cancer at the time of radical inguinal orchidectomy.
Methods: An international online survey of urologists who perform radical orchidectomy for testicular cancer was developed. The recruitment process used social media and the emailing lists of national urological societies.
Even though Leydig cell tumor (LCT) represents the most common neoplasia among testicular sex cord-stromal tumors (SCSTs), it is a rare condition, comprising 1-2% of all testicular tumors, with a 10% risk of malignancy most commonly located in retroperitoneal lymph nodes. LCTs may demonstrate various clinical manifestations - from asymptomatic intratesticular swelling through nonspecific symptoms such as loss of libido, impotence or infertility, up to feminizing or virilizing syndromes due to hormonal activity of the tumor. This article presents a case of Leydig cell tumor that was associated with azoospermia what have rarely been reported worldwide.
View Article and Find Full Text PDFEur J Pharmacol
January 2025
Department of Physiology, Zanjan Branch, Islamic Azad University, Zanjan, Iran.
Carvacrol is a common ingredient in the pharmaceutical, cosmetic, and perfume industries. It possesses various pharmaceutical properties including pain relief, anti-cell death, antioxidant, anti-cancer, and anti-inflammatory effects. We investigated the protective impact of carvacrol on infertility caused by varicocele in rats.
View Article and Find Full Text PDFUrol Case Rep
January 2025
Faculty member, Faculty of Medicine, Pathology Department, Damascus University, Damascus, Syrian Arab Republic.
Leydig cell tumors (LCTs) are rare testicular neoplasms, representing 1-3% of all testicular tumors. A 65-year-old male presented with a painless left scrotal mass. Ultrasound revealed a 61 × 53 × 35 mm tumor with heterogeneous echogenicity and abundant blood supply.
View Article and Find Full Text PDFUrology
January 2025
Department of Urology, University of Rochester Medical Center, Rochester, NY, USA. Electronic address:
This review examines the historical evolution of testicular cancer (TCa) treatment, emphasizing the transformative impact of World War II. Prior to the war, cases of more than 50 testicular tumors were exceedingly rare. The mobilization of American troops, especially after the German Blitz, resulted in widespread military health screenings, leading to a surge in incidental TCa diagnoses during the 1940s.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!